in an all-stock deal valued at about $3 billion to build scale in the competitive market for spinal devices.
NuVasive shareholders will receive 0.75 of Globus shares, implying a per-share offer of $57.72 and a premium of about 26% to Wednesday's close. Shares of Globus Medical fell more than 17%, with analysts raising concerns around deals in spinal device space.Similar deals in the spinal device market, such as Stryker
acquiring K2M Group and several others, have had more revenue "dis-synergies and loss of integration" than other areas of medtech over the years, said Baird analyst Jeffrey Johnson."To double-down on spine is somewhat surprising in our view and adds a lower growth organization," said BTIG analyst Ryan Zimmerman.
I touch I was getting two billion but I'll take my three billion failed diplomatic experiment safety and Liberty 🗽💳✔️
Canada Canada Latest News, Canada Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: MarketWatch - 🏆 3. / 97 Read more »